A股異動 | 德方納米漲7% 年產11萬噸磷酸錳鐵鋰項目已投產
格隆匯1月17日丨德方納米(300769.SZ)大幅拉昇漲至7%,現報252元,暫成交7.88億元,總市值440億元。公司在接受機構調研時表示,公司的年產11萬噸磷酸錳鐵鋰項目已經投產,正在進行產能爬坡。產品的測試指標目前已通過了下游客户的驗證,從當前的驗證結果來看,公司的磷酸錳鐵鋰在新能源乘用車動力電池上具有突出優勢。中銀證券此前指出,目前磷酸鐵鋰行業需求仍然保持旺盛,價格維持高位,預計公司全年盈利能力有望得到支撐,全年單噸盈利有望保持在1.3萬元以上。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.